Stallion India

Which are the latest news on Stallion India?

Why is Stallion India Fluorochemicals Ltd falling/rising?

As of 05-Sep, Stallion India Fluorochemicals Ltd's stock price is at 207.60, unchanged from the previous session, and has declined 2.21% over the last two days. Despite being net-debt free and showing strong long-term growth, the stock has decreased by 22.68% over the past month amid reduced investor participation.

As of 05-Sep, Stallion India Fluorochemicals Ltd's stock price is currently at 207.60, showing no change from the previous trading session. The stock has been experiencing a decline, having underperformed its sector by 0.29% today and has fallen consecutively for the last two days, resulting in a total decrease of 2.21% during this period. <BR><BR>In the past week, the stock has decreased by 2.58%, while over the last month, it has seen a significant drop of 22.68%. This decline is notable compared to the Sensex, which has only decreased by 0.97% in the same week and 2.44% over the month. Additionally, there has been a decrease in investor participation, with the delivery volume on September 3 falling by 32.51% compared to the five-day average, indicating reduced trading interest.<BR><BR>Despite these negative trends, the company remains net-debt free and has shown healthy long-term growth, with operating profit increasing at an annual rate of 61.09%. Furthermore, the company reported its highest quarterly net sales and operating profit figures in June, which suggests strong operational performance. However, the recent price movements and declining investor participation indicate that the stock is currently facing downward pressure.

What does Stallion India do?

Stallion India Fluorochemicals Ltd, a small-cap company incorporated in 2002 and converted to a public company in 2023, operates in the Other Chemical products industry, reporting net sales of 121 Cr and a net profit of 19 Cr for June 2026. Key metrics include a P/E of 47.00 and a market cap of INR 2,507 Cr.

Overview:<BR>Stallion India Fluorochemicals Ltd operates in the Other Chemical products industry and is categorized as a Small Cap company.<BR><BR>History:<BR>The company was incorporated in 2002 as a Private Limited Company in Mumbai and later converted to a Public Limited Company on October 5, 2023. The most recent quarterly results reported net sales and net profit for June 2026.<BR><BR>Financial Snapshot:<BR>Net Sales: 121 Cr (Quarterly Results - Jun 2026) <BR>Net Profit: 19 Cr (Quarterly Results - Jun 2026) <BR>Market Cap: INR 2,507 Cr (Small Cap)<BR><BR>Key Metrics:<BR>P/E: 47.00 <BR>Industry P/E: 43 <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.59 <BR>Return on Equity: 7.65% <BR>Price to Book: 3.62 <BR><BR>Contact Details:<BR>Registrar Address: Not available. <BR>Phone: N/A <BR>Email: N/A <BR>Website: N/A

Who are the peers of the Stallion India?

Stallion India's peers include PCBL Chemical, Ellen.Indl.Gas, Refex Industries, and others, with varying management risks and growth rates. Stallion India has a Below Average management risk, Good growth, and a 1-year return of 66.38%, higher than Ellen.Indl.Gas but lower than Beezaasan Exp. at 181.32%.

Peers: The peers of Stallion India are PCBL Chemical, Ellen.Indl.Gas, Refex Industries, Prem. Explosives, GOCL Corpn., Keltech Energies, Beezaasan Exp., DIC India, and Monolithisch Ind.<BR><BR>Quality Snapshot: Excellent management risk is observed at Ellen.Indl.Gas and Beezaasan Exp., while Average management risk is found at PCBL Chemical, Refex Industries, Prem. Explosives, GOCL Corpn., Keltech Energies, DIC India, and Monolithisch Ind, and the rest. Below Average management risk is noted for Stallion India. Growth is Excellent at Refex Industries and Monolithisch Ind, Good at Stallion India, Keltech Energies, and the rest, while Average growth is seen at PCBL Chemical, Ellen.Indl.Gas, and the rest, and Below Average growth is noted for Prem. Explosives, GOCL Corpn., and DIC India. Capital Structure is Excellent at Stallion India, Ellen.Indl.Gas, Beezaasan Exp., and DIC India, Good at Refex Industries, Keltech Energies, and the rest, Average at PCBL Chemical, and Below Average at GOCL Corpn.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Beezaasan Exp. at 181.32%, while the lowest is Ellen.Indl.Gas at -37.69%. Stallion India's own 1-year return is 66.38%, which is significantly higher than Ellen.Indl.Gas but lower than Beezaasan Exp. Additionally, the peers with negative six-month returns are Refex Industries and DIC India.

How big is Stallion India?

As of 31st August, Stallion India Fluorochemicals Ltd has a market capitalization of 2,507.00 Cr, with recent Net Sales of 441.65 Cr and a Net Profit of 52.05 Cr.

As of 31st August, Stallion India Fluorochemicals Ltd has a market capitalization of 2,507.00 Cr, categorizing it as a Small Cap company.<BR><BR>In the latest four quarters, Stallion India reported Net Sales of 441.65 Cr and a Net Profit of 52.05 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, with Shareholder's Funds amounting to 300.84 Cr and Total Assets of 327.21 Cr.

Should I buy, sell or hold Stallion India Fluorochemicals Ltd?

When is the next results date for Stallion India Fluorochemicals Ltd?

The next results date for Stallion India Fluorochemicals Ltd is 12 August 2026.

The next results date for Stallion India Fluorochemicals Ltd is scheduled for 12 August 2026.

Are Stallion India Fluorochemicals Ltd latest results good or bad?

Stallion India Fluorochemicals Ltd's latest results are mixed, with a net profit decline of 17.64% year-on-year and a significant revenue drop of 27.43%, raising concerns about demand sustainability. While there was a 40.08% profit growth over nine months, the sharp revenue contraction and stock decline indicate investor skepticism about future growth.

The latest results for Stallion India Fluorochemicals Ltd indicate a mixed performance. In Q4 FY26, the company reported a net profit of ₹10.93 crores, which is a decline of 17.64% year-on-year and a slight decrease of 1.80% quarter-on-quarter. Revenue for the same quarter was ₹109.99 crores, reflecting a significant year-on-year decline of 27.43%, although it showed a modest sequential growth of 5.10%.<BR><BR>While the operating margin improved to 14.86%, up 370 basis points from the previous quarter, the overall revenue contraction raises concerns about the sustainability of demand. The company's stock has also seen a dramatic decline of 61.13% from its 52-week high, reflecting investor apprehension regarding its growth prospects in a competitive market.<BR><BR>On a more positive note, the nine-month performance for FY26 showed a net profit growth of 40.08% compared to the previous year, indicating some resilience in the business. However, the elevated valuation metrics, with a P/E ratio of 35.23 and a price-to-book ratio of 5.12, suggest limited room for error in execution.<BR><BR>Overall, the results can be characterized as concerning, particularly due to the sharp revenue decline and the market's reaction, which reflects skepticism about the company's ability to maintain its growth trajectory. Investors should be cautious and monitor upcoming quarters for signs of stabilization and recovery.

Is Stallion India overvalued or undervalued?

As of November 26, 2025, Stallion India is considered overvalued with a PE ratio of 45.93, an EV to EBITDA of 29.40, and a PEG ratio of 0.00, significantly higher than its peers and has underperformed against the Sensex with a 1-month return of -41.72%.

As of 26 November 2025, Stallion India has moved from a valuation grade of very expensive to expensive. The company is currently considered overvalued. Key ratios include a PE ratio of 45.93, an EV to EBITDA of 29.40, and a ROCE of 19.73%. <BR><BR>In comparison to its peers, Stallion India's PE ratio is significantly higher than Godrej Industries, which stands at 36.8, and Deepak Nitrite at 40.22. The PEG ratio for Stallion is 0.00, indicating no growth expectations priced into the stock, which is concerning given its high valuation. Additionally, Stallion India has underperformed against the Sensex, with a 1-month return of -41.72% compared to the Sensex's 1.66% return, further reinforcing the notion that the stock may be overvalued.

How has been the historical performance of Stallion India?

Stallion India has shown significant growth over the past three years, with net sales increasing from 225.50 Cr in Mar'23 to 377.45 Cr in Mar'25, and profit after tax rising from 9.75 Cr to 32.33 Cr, reflecting strong operational efficiency and profitability. Total assets also grew substantially, indicating robust financial performance across key metrics.

Answer:<BR>The historical performance of Stallion India shows significant growth in various financial metrics over the past three years.<BR><BR>Breakdown:<BR>Stallion India's net sales increased from 225.50 Cr in Mar'23 to 377.45 Cr in Mar'25, indicating a strong upward trend. Total operating income followed suit, rising from 225.50 Cr in Mar'23 to 377.45 Cr in Mar'25. The company's total expenditure also grew, from 210.46 Cr in Mar'23 to 329.73 Cr in Mar'25, primarily driven by raw material costs, which surged from 195.58 Cr to 292.95 Cr during the same period. Operating profit (PBDIT) saw a substantial rise from 15.60 Cr in Mar'23 to 49.74 Cr in Mar'25, reflecting improved operational efficiency. Profit before tax increased from 12.97 Cr to 42.43 Cr, while profit after tax rose from 9.75 Cr to 32.33 Cr, showcasing a robust growth in profitability. The earnings per share (EPS) also improved significantly, from 1.77 in Mar'23 to 4.08 in Mar'25. On the balance sheet, total assets grew from 125.43 Cr in Mar'23 to 327.21 Cr in Mar'25, with total liabilities increasing from 125.43 Cr to 327.21 Cr as well. The cash flow from financing activities remained positive, contributing to a net cash inflow of 42.00 Cr in Mar'25, up from 15.00 Cr in Mar'24. Overall, Stallion India has demonstrated a strong financial performance with consistent growth across key metrics.

Who are the top shareholders of the Stallion India?

The top shareholder of Stallion India is Shazad Sheriar Rustomji, holding 67.88% of the shares. Other shareholders include 12 Foreign Institutional Investors with 3.32%, Geetu Yadav as the highest public shareholder at 4.16%, and individual investors holding 16.94%, with no pledged promoter holdings or mutual funds involved.

The top shareholders of Stallion India are primarily the promoters, with Shazad Sheriar Rustomji holding the largest share at 67.88%. In addition to the promoters, there are 12 Foreign Institutional Investors (FIIs) collectively holding 3.32% of the company. The highest public shareholder is Geetu Yadav, who owns 4.16%. Individual investors account for 16.94% of the total shareholding. Notably, there are no pledged promoter holdings and no mutual funds currently holding shares in the company.

Has Stallion India declared dividend?

No Dividend History Available